Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. 10x Genomics Inc shares valued at $118,529 were sold by Saxonov Serge on May 22 ’24. At $24.30 per share, Saxonov Serge sold 4,877 shares. The insider’s holdings dropped to 889,641 shares worth approximately $17.35 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hindson Benjamin J. sold 4,087 shares, netting a total of over 99,329 in proceeds. Following the sale of shares at $24.30 each, the insider now holds 350,055 shares.
Before that, McAnear Justin J. had sold 2,936 shares from its account. In a trade valued at $71,355, the Chief Financial Officer traded 10x Genomics Inc shares for $24.30 each. Upon closing the transaction, the insider’s holdings decreased to 2,936 shares, worth approximately $2.85 million.
As published in a research note from Guggenheim on June 25, 2024, 10x Genomics Inc [TXG] has been rated down from a Buy to a Neutral. As of May 01, 2024, TD Cowen has decreased its “Buy” rating to a “Hold” for TXG. Earlier on December 14, 2023, Guggenheim initiated its rating. Their recommendation was “a Buy” for TXG stock.
Analyzing TXG Stock Performance
During the last five days, there has been a drop of approximately -1.37%. Over the course of the year, 10x Genomics Inc shares have dropped approximately -65.15%. Shares of the company reached a 52-week high of $55.96 on 01/02/24 and a 52-week low of $19.20 on 06/20/24. A 50-day SMA is recorded $24.32, while a 200-day SMA reached $38.52. Nevertheless, trading volume fell to 1.43 million shares from 1.35 million shares the previous day.
Support And Resistance Levels for 10x Genomics Inc (TXG)
According to the 24-hour chart, there is a support level at 19.28, which, if violated, would cause prices to drop to 19.07. In the upper region, resistance lies at 19.79. The next price resistance is at 20.08. RSI (Relative Strength Index) is 28.72 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.90, which suggests the price will decrease in the coming days. Percent R is at 91.53%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
